1. Home
  2. NREF vs AVIR Comparison

NREF vs AVIR Comparison

Compare NREF & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

SELL

Current Price

$11.24

Market Cap

298.0M

Sector

Real Estate

ML Signal

SELL

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

SELL

Current Price

$4.14

Market Cap

334.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NREF
AVIR
Founded
2019
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
298.0M
334.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NREF
AVIR
Price
$11.24
$4.14
Analyst Decision
Hold
Buy
Analyst Count
3
3
Target Price
★ $14.50
$9.00
AVG Volume (30 Days)
66.3K
★ 275.9K
Earning Date
11-05-2026
11-09-2026
Dividend Yield
★ 16.30%
N/A
EPS Growth
N/A
★ 3.00
EPS
★ N/A
N/A
Revenue
N/A
★ $351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.05
N/A
P/E Ratio
$4.78
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.16
$2.93
52 Week High
$18.43
$6.45

Technical Indicators

Market Signals
Indicator
NREF
AVIR
Relative Strength Index (RSI) 20.74 41.48
Support Level N/A $4.06
Resistance Level $16.04 $4.54
Average True Range (ATR) 0.68 0.24
MACD -0.27 0.03
Stochastic Oscillator 2.47 38.74

Price Performance

Historical Comparison
NREF
AVIR

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: